Alpha 2.0
Login Register
» Authors » Kunihisa Kohno

Kunihisa Kohno

Explore the profile of Kunihisa Kohno including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 465
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Pharmacology
Top 10 Co-Authors
Hiroshi Ito
Kazufumi Nakamura
Toru Miyoshi
Hiroshi Morita
Nobuhiro Nishii
Satoshi Nagase
Kengo F Kusano
Tohru Ohe
Norihisa Toh
Makoto Nakahama
Published In
Circ J
Acta Med Okayama
Cardiovasc Pathol
Int J Cardiol
PLoS One
Affiliations
Soon will be listed here.
Recent Articles
1.
The number of circulating CD34-positive cells is an independent predictor of coronary artery calcification progression: Sub-analysis of a prospective multicenter study
Ichikawa K, Miyoshi T, Osawa K, Miki T, Kohno K, Nakamura K, et al.
Cardiol J . 2021 Nov; 29(3):423-431. PMID: 34787888
Background: Decreases in circulating CD34-positive cells are associated with increases in cardiovascular events. We investigated the association between the number of CD34-positive cells and the progression of coronary artery calcification...
2.
Possible Protective Effect of Remote Ischemic Preconditioning on Acute Kidney Injury Following Elective Percutaneous Coronary Intervention: Secondary Analysis of a Multicenter, Randomized Study
Otsuka H, Miyoshi T, Ejiri K, Kohno K, Nakahama M, Doi M, et al.
Acta Med Okayama . 2021 Mar; 75(1):45-53. PMID: 33649613
Remote ischemic preconditioning (RIPC) is a promising strategy for protecting against ischemic reperfusion injury. This study is a secondary analysis of a randomized study that aimed to evaluate the effect...
3.
Decrease in oxidized high-density lipoprotein is associated with slowed progression of coronary artery calcification: Subanalysis of a prospective multicenter study
Miki T, Miyoshi T, Kotani K, Kohno K, Asonuma H, Sakuragi S, et al.
Atherosclerosis . 2019 Feb; 283:1-6. PMID: 30769272
Background And Aims: Oxidized high-density lipoprotein (oxHDL) is characterized by reduced anti-inflammatory properties compared with HDL. However, the role of oxHDL in the pathogenesis of coronary artery calcification (CAC), a...
4.
Tobacco smoking protective effect via remote ischemic preconditioning on myocardial damage after elective percutaneous coronary intervention: Subanalysis of a randomized controlled trial
Ejiri K, Miyoshi T, Kohno K, Nakahama M, Doi M, Munemasa M, et al.
Int J Cardiol Heart Vasc . 2019 Jan; 22:55-60. PMID: 30603663
Background: Remote ischemic preconditioning (RIPC) is promising for preventing periprocedural myocardial damage (pMD) in patients undergoing percutaneous coronary intervention (PCI). However, the impact of RIPC on pMD on smokers is...
5.
Anti-tachycardia pacing degenerated fast ventricular tachycardia into undetectable life-threatening tachyarrhythmia in a patient with non-ischemic dilated cardiomyopathy
Yunoki K, Nishii N, Morita H, Iwasaki J, Nagase S, Nakamura K, et al.
J Cardiol Cases . 2018 Dec; 2(3):e159-e162. PMID: 30546708
A 45-year-old man with dilated cardiomyopathy was admitted to our hospital due to congestive heart failure (CHF). Despite the optimal medical treatment, his condition had not improved because of severe...
6.
High Baseline Lipoprotein(a) Level as a Risk Factor for Coronary Artery Calcification Progression: Sub-analysis of a Prospective Multicenter Trial
Ida J, Kotani K, Miyoshi T, Nakamura K, Kohno K, Asonuma H, et al.
Acta Med Okayama . 2018 Jun; 72(3):223-230. PMID: 29925999
Lipoprotein(a), or Lp(a), is a low-density lipoprotein-like particle largely independent of known risk factors for, and predictive of, cardiovascular disease (CVD). We investigated the association between baseline Lp(a) levels and...
7.
Protective Effect of Remote Ischemic Preconditioning on Myocardial Damage After Percutaneous Coronary Intervention in Stable Angina Patients With Complex Coronary Lesions　- Subanalysis of a Randomized Controlled Trial
Ejiri K, Miyoshi T, Kohno K, Nakahama M, Doi M, Munemasa M, et al.
Circ J . 2018 Apr; 82(7):1788-1796. PMID: 29669963
Background: The effect of remote ischemic preconditioning (RIPC) on periprocedural myocardial damage (pMD) in patients undergoing percutaneous coronary intervention (PCI) is controversial. The aim of this study was to investigate...
8.
Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC)
Kawakita N, Ejiri K, Miyoshi T, Kohno K, Nakahama M, Doi M, et al.
PLoS One . 2018 Apr; 13(4):e0194623. PMID: 29659585
Background: Our previous study examined an effect of remote ischemic preconditioning (RIPC) or intravenous nicorandil on reduction of periprocedural myocardial injury (pMI) following percutaneous coronary intervention (PCI) in patients with...
9.
Effect of Intensive and Standard Pitavastatin Treatment With or Without Eicosapentaenoic Acid on Progression of Coronary Artery Calcification Over 12 Months　- Prospective Multicenter Study
Miyoshi T, Kohno K, Asonuma H, Sakuragi S, Nakahama M, Kawai Y, et al.
Circ J . 2017 Sep; 82(2):532-540. PMID: 28867681
Background: The effect of lipid-lowering agents on progression of coronary artery calcification (CAC) remains unclear. We evaluated the effects of pitavastatin 2 mg/day (PIT2), pitavastatin 4 mg/day (PIT4), and PIT2...
10.
Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial
Miyoshi T, Ejiri K, Kohno K, Nakahama M, Doi M, Munemasa M, et al.
Int J Cardiol . 2017 Feb; 236:36-42. PMID: 28214082
Background: The effect of remote ischemic preconditioning (RIPC) and nicorandil on periprocedural myocardial injury (pMI) in patients with planned percutaneous coronary intervention (PCI) remains controversial. The aim of this randomized...